Moderna, Eli Lilly and Apple Rise Premarket
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, December 15th. Please refresh for updates. Eli Lilly (NYSE:LLY) stock rose 2.1% after the drugmaker said it would buy Prevail Therapeutics (NASDAQ:PRVL), up 86%, in a deal valued at $1.04 billion, to expand its presence in gene therapy. It also raised its quarterly dividend by 15%. ...
Continue reading